Global  

Trusted News Discovery Since 2008
One News Page
One News Page > Press Releases News > Xeris Pharmaceuticals Announces $0 Copay for Gvoke™ PFS for People With Diabetes

Xeris Pharmaceuticals Announces $0 Copay for Gvoke™ PFS for People With Diabetes

Business Wire Thursday, 26 March 2020 ()
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced a limited-time $0 copay offering for commercially eligible patients effective now through April 30, 2020 as a response to the COVID-19 pandemic. “In this time of uncertainty, people with diabetes need a glucagon product they can easily ad
0
shares
ShareTweetSavePostSend
 

Recent related news from verified sources

The Latest: Coronavirus cases in Africa near 5,000

The Latest on the coronavirus pandemic. The new coronavirus causes mild or moderate symptoms for most people. For some, especially older adults and people with...
SeattlePI.com

The Latest: SKorea households to get financial giveaways

The Latest on the coronavirus pandemic. The new coronavirus causes mild or moderate symptoms for most people. For some, especially older adults and people with...
SeattlePI.com

You Might Like


Tweets about this

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.